Delayed Nasdaq  -  05/20 04:00:01 pm EDT
2151.82 USD   +0.25%
05/21Wingcopter Details Plans to Deploy 12,000 Drones Across Africa
05/20Amazon Testing Service With Gig Economy Drivers to Deliver From Malls
05/20Wall St rises as growth stocks gain after two days of selloff
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Maker of Walmart, Amazon store-brand baby formulas sees shortages through rest of 2022

05/13/2022 | 03:39pm EDT
Birds are seen on the logo of generic drugmaker Perrigo Co outside their new factory in the city of Yeruham

NEW YORK, May 13 (Reuters) - Perrigo Company PLC, which makes store-brand baby formulas for retailers, including Walmart Inc and Inc, expects shortages and heightened demand to last for the "balance of the year," Chief Executive Murray Kessler told Reuters in an interview.

The Biden administration this week has come under increasing pressure to address a baby formula shortage, which has roots in a February recall of some formulas by one of the nation's main manufacturers, Abbott Laboratories.

"We have stepped up and are killing ourselves to do everything we can," Kessler said.

Perrigo's formula manufacturing facilities in Ohio and Vermont are now running at 115% of capacity, Kessler said.

At the request of the U.S. Food and Drug Administration, Perrigo is focusing on four items, the store-brand versions of Similac Pro Sensitive and Pro Advance and Enfamil Gentle Ease and Infant, Kessler said.

The company added that it is making other formulas as well. It also has a smaller business making some national formula brands, including Bobbie.

The closure of Abbott's infant-formula plant in Sturgis, Michigan, exacerbated national pandemic-related shortages, leading to empty shelves in big box stores and supermarkets and panicked parents. Abbott's brands include Similac formulas.

Perrigo is working with retailers including Walmart and Target Corp so they "get something each week," Kessler said. Retailers' allocations are based on an average of what the retailers received prior to "this crisis," he said.

Some retailers including CVS Health Corp and Target are rationing baby formula.

The White House on Thursday announced steps it is taking to alleviate the shortage, including permitting more imports. President Joe Biden said on Friday he expects more formula on shelves in weeks.

French food and beverage company Danone SA, which also makes infant formulas, said the "unexpected Abbott Nutrition recall in February has led to a surge in demand in the U.S. market.

"We are in discussions with the U.S. authorities to see how we can support them in addressing their shortages.”

Of the total U.S. baby formula market, Perrigo makes up roughly 8%, Kessler said, adding that it has gained share as it has worked to satisfy the soaring demand.

Due to "massive inflation," Perrigo raised prices by about 3% in the first quarter, Kessler said.

The company has ordered materials to meet the heightened level of demand throughout the year, he said.

Bobbie, a European-style infant formula new to the market, saw its customer count double the first week after the recall of Abbott formulas, and it has continued to climb, CEO Laura Modi told Reuters.

Perrigo manufacturers Bobbie's formula, but can only meet about 50% of the company's demand, Modi said, leading it to stop taking new customers. Perrigo can meet 100% of Bobbie's current customer needs, she said.

Bobbie has about 70,000 customers.

Abbott closed its manufacturing facility in Michigan after complaints of bacterial contamination.

The FDA later cited five bacterial infections reported in babies given the company's formula, including two deaths. Abbott has said its plants are "not likely the source of infection" and is planning on re-opening the facility in the next two weeks.

(Reporting by Jessica DiNapoli in New York and Richa Naidu in London Editing by Nick Zieminski and Marguerita Choy)

© Reuters 2022
Stocks mentioned in the article
ChangeLast1st jan.
AMAZON.COM, INC. 0.25% 2151.82 Delayed Quote.-35.46%
CLASS III MILK FUTURES (DC) - CMG (ELECTRONIC)/C1 -0.12% 25.09 End-of-day quote.36.37%
CLASS IV MILK?FUTURES (GDK) - CMG (ELECTRONIC)/C1 0.00% 25.04 End-of-day quote.26.02%
CVS HEALTH CORPORATION 1.92% 94.93 Delayed Quote.-7.98%
DANONE 1.40% 54.87 Real-time Quote.0.51%
DRY WHEY?FUTURES (DY) - CMG (ELECTRONIC)/C1 0.00% 66 End-of-day quote.3.29%
NONFAT DRY MILK FUTURES (GNF) - CMG (ELECTRONIC)/C1 -0.30% 180.925 End-of-day quote.17.40%
PERRIGO COMPANY PLC 1.49% 38.14 Delayed Quote.-1.95%
PLC S.P.A. 0.00% 2.06 Delayed Quote.-0.96%
S&P GSCI CLASS III MILK (USD) -0.80% 187.1678 Real-time Quote.18.97%
TARGET CORPORATION 1.26% 155.36 Delayed Quote.-33.71%
WALMART INC. 0.11% 119.2 Delayed Quote.-17.71%
All news about AMAZON.COM, INC.
05/21Wingcopter Details Plans to Deploy 12,000 Drones Across Africa
05/20Amazon Testing Service With Gig Economy Drivers to Deliver From Malls
05/20Wall St rises as growth stocks gain after two days of selloff
05/20WALL STREET STOCK EXCHANGE : China triggers rebound on Wall Street
05/20Hask Beauty Enters into an Exclusive Partnership with Amazon for Their Vegan Hask Body ..
05/, Flipkart, PE Firms Reportedly Among Potential Investors in Metropolis Healt..
05/20AMAZON COM INC : Credit Suisse remains its Buy rating
05/19Australia's Woolworths offers to buy majority stake in
05/19Schroders to oppose Amazon, Meta, Alphabet over worker, digital rights
05/19S&P 500, Dow slip as Cisco drags, growth stocks lead Nasdaq rebound
More news
Analyst Recommendations on AMAZON.COM, INC.
More recommendations
Financials (USD)
Sales 2022 526 B - -
Net income 2022 8 182 M - -
Net cash 2022 42 943 M - -
P/E ratio 2022 135x
Yield 2022 -
Capitalization 1 095 B 1 095 B -
EV / Sales 2022 2,00x
EV / Sales 2023 1,67x
Nbr of Employees 1 608 000
Free-Float 86,1%
Duration : Period :, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends AMAZON.COM, INC.
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus BUY
Number of Analysts 53
Last Close Price 2 151,82 $
Average target price 3 660,91 $
Spread / Average Target 70,1%
EPS Revisions
Managers and Directors
Andrew R. Jassy President, Chief Executive Officer & Director
Brian T. Olsavsky Chief Financial Officer & Senior Vice President
Jeffrey P. Bezos Executive Chairman
Patricia Q. Stonesifer Independent Director
Jonathan Jake Rubinstein Lead Independent Director
Sector and Competitors
1st jan.Capi. (M$)
AMAZON.COM, INC.-35.46%1 094 675
JD.COM, INC.-25.55%79 709
COUPANG, INC.-55.75%22 912
ETSY, INC.-64.22%9 959
MONOTARO CO., LTD.-7.53%7 449